Study short name: PrEMO
Study full name: An Open-label Study of Probiotic and Hen’s Egg or Cow’s Milk Oral Immunotherapy (Probiotic and Egg or Milk Oral Immunotherapy: PrEMO study).
Principle Investigator: Mimi Tang
Administering Institute: Murdoch Children’s Research Institute
Major funding source: Prota Therapeutics
Study focus: Treatment
Study design: Intervention
Main study aim: To assess the rate of sustained unresponsiveness and desensitisation following 18 months of probiotic egg oral immunotherapy (OIT) or probiotic milk OIT.
Additional study information: This is a pilot study investigating whether probiotic given in combination with egg or milk OIT is effective at inducing sustained unresponsiveness in egg and/or milk allergic children.
Study Population: The participants in this study are aged between 5 and 17 years old at time of enrolment. Participants are allergic to egg or milk, and may have additional food allergies.
Study status: Recruitment closed. Data collection ongoing, through mid-2021.
Where can I find more information?
Australia New Zealand Clinical Trials Registry: https://www.australianclinicaltrials.gov.au/anzctr/trial/ACTRN12619000306112
Study contact: [email protected]
Last modified: August 20th 2019 | Date created: May 9th 2019